Cargando…
Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation
Saponin-based adjuvants (SBAs) are promising new adjuvants that stand out as they not only enforce CD4 + T cell-mediated immunity and antibody responses, but also induce an unprecedented level of antigen cross-presentation by dendritic cells (DC) and subsequent CD8 + T cell activation. We discovered...
Autores principales: | Huis in ’t Veld, Lisa G. M., Ho, Nataschja I., Wassink, Melisssa, den Brok, Martijn H., Adema, Gosse J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994093/ https://www.ncbi.nlm.nih.gov/pubmed/35396971 http://dx.doi.org/10.1007/s00018-022-04253-x |
Ejemplares similares
-
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
por: Ho, Nataschja I., et al.
Publicado: (2018) -
Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation
por: den Brok, Martijn H., et al.
Publicado: (2016) -
Saponin-based adjuvants enhance antigen cross-presentation in human CD11c(+) CD1c(+) CD5(−) CD163(+) conventional type 2 dendritic cells
por: Ho, Nataschja I, et al.
Publicado: (2023) -
Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes
por: Raaijmakers, Tonke K, et al.
Publicado: (2020) -
Autophagy regulates long‐term cross‐presentation by murine dendritic cells
por: Ho, Nataschja I., et al.
Publicado: (2021)